v3 Template
T

TandemAI

Biotechnology and Pharmaceuticals ~50 employees
Founded
--
Employees (Est.)
~50
5 leaders known
Total Funding
$57.0M
Funding Rounds
2
Last Funding
2025-11-13

About TandemAI

TandemAI is an integrated drug discovery CRO that aims to redefine the drug discovery process by combining AI and physics-based platforms with wet lab experimentation. Their mission is to streamline workflows, enhance collaboration, and accelerate research through innovative technology and supportive partnerships, ultimately reimagining the future of drug discovery.

Products & Services

TandemViz™:A user-friendly, cloud-based platform for integrated drug discovery, combining physics-based and AI tools to manage research pipelines, collaborate with teams, and streamline computational and experimental workflows.
Computational Drug Discovery:Services focused on hit identification and hit-to-lead optimization using advanced computational methods.
Digital Assays & Workflows:Solutions to manage and streamline digital assays and experimental workflows.
Medicinal Chemistry & Synthesis:Wet lab services for medicinal chemistry and chemical synthesis to support drug discovery.
Biological Assays:Services for conducting biological assays as part of the drug discovery process.
Peptide Platform:A specialized platform for peptide-based drug discovery and development.

Specialties

AI-based drug discovery Physics-based drug discovery Computational chemistry Wet lab services Integrated drug discovery platforms

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A extension
T: -
FT: Series A extension
A: 22000000
MR: -
FA: $22 million
FAN: 22000000
D: 2025-11-13
FD: 2025-11-13
2 investors
2 RT: Series A
T: -
FT: Series A
A: 35000000
MR: -
FA: 35 million
FAN: 35000000
D: 2023-03-01
FD: 2023-03-01
4 investors
Series A extension Latest
2025-11-13
$22.0M
2 investors (Pro only)
Series A 2023-03-01
$35.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jeff He

Co-Founder and Chief Executive Officer

K

Kerry Blanchard

President, R&D

A

Albert Pan

Chief Technology Officer

V

Ved Srivastava

CSO, Peptide

L

Lanny Sun

Co-Founder and Executive Chairman

View 2 more team members with Pro

Unlock Full Team Directory

Recent News

TandemAI Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology and Pharmaceuticals
Company Size
~50 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro